Cellular adhesion differences at a blood brain barrier model between Natalizumab (Tysabri) Standard Interval Dosing and Extended Interval Dosing Therapy:
Gespeichert in:
| 1. Verfasser: | |
|---|---|
| Format: | Abschlussarbeit Buch |
| Sprache: | English |
| Veröffentlicht: |
Münster
2021
|
| Schlagworte: | |
| Beschreibung: | 56 Blätter Illustrationen, Diagramme |
Internformat
MARC
| LEADER | 00000nam a2200000 c 4500 | ||
|---|---|---|---|
| 001 | BV047460969 | ||
| 003 | DE-604 | ||
| 005 | 00000000000000.0 | ||
| 007 | t | ||
| 008 | 210910s2021 a||| m||| 00||| eng d | ||
| 035 | |a (OCoLC)1268198123 | ||
| 035 | |a (DE-599)BVBBV047460969 | ||
| 040 | |a DE-604 |b ger |e rda | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-355 | ||
| 084 | |a 610 |2 sdnb | ||
| 100 | 1 | |a Richter, Jannis |e Verfasser |4 aut | |
| 245 | 1 | 0 | |a Cellular adhesion differences at a blood brain barrier model between Natalizumab (Tysabri) Standard Interval Dosing and Extended Interval Dosing Therapy |c vorgelegt von Richter, Jannis |
| 264 | 1 | |a Münster |c 2021 | |
| 300 | |a 56 Blätter |b Illustrationen, Diagramme | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 502 | |b Dissertation |c Westfälische Wilhelms-Universität Münster |d 2021 | ||
| 546 | |a Zusammenfassung deutsch, Text englisch | ||
| 655 | 7 | |0 (DE-588)4113937-9 |a Hochschulschrift |2 gnd-content | |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-032862739 | ||
Datensatz im Suchindex
| _version_ | 1804182766762328064 |
|---|---|
| adam_txt | |
| any_adam_object | |
| any_adam_object_boolean | |
| author | Richter, Jannis |
| author_facet | Richter, Jannis |
| author_role | aut |
| author_sort | Richter, Jannis |
| author_variant | j r jr |
| building | Verbundindex |
| bvnumber | BV047460969 |
| ctrlnum | (OCoLC)1268198123 (DE-599)BVBBV047460969 |
| discipline | Medizin |
| discipline_str_mv | Medizin |
| format | Thesis Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01019nam a2200289 c 4500</leader><controlfield tag="001">BV047460969</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">210910s2021 a||| m||| 00||| eng d</controlfield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)1268198123</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV047460969</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rda</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-355</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">610</subfield><subfield code="2">sdnb</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Richter, Jannis</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Cellular adhesion differences at a blood brain barrier model between Natalizumab (Tysabri) Standard Interval Dosing and Extended Interval Dosing Therapy</subfield><subfield code="c">vorgelegt von Richter, Jannis</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Münster</subfield><subfield code="c">2021</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">56 Blätter</subfield><subfield code="b">Illustrationen, Diagramme</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="502" ind1=" " ind2=" "><subfield code="b">Dissertation</subfield><subfield code="c">Westfälische Wilhelms-Universität Münster</subfield><subfield code="d">2021</subfield></datafield><datafield tag="546" ind1=" " ind2=" "><subfield code="a">Zusammenfassung deutsch, Text englisch</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)4113937-9</subfield><subfield code="a">Hochschulschrift</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-032862739</subfield></datafield></record></collection> |
| genre | (DE-588)4113937-9 Hochschulschrift gnd-content |
| genre_facet | Hochschulschrift |
| id | DE-604.BV047460969 |
| illustrated | Illustrated |
| index_date | 2024-07-03T18:06:28Z |
| indexdate | 2024-07-10T09:12:46Z |
| institution | BVB |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-032862739 |
| oclc_num | 1268198123 |
| open_access_boolean | |
| owner | DE-355 DE-BY-UBR |
| owner_facet | DE-355 DE-BY-UBR |
| physical | 56 Blätter Illustrationen, Diagramme |
| publishDate | 2021 |
| publishDateSearch | 2021 |
| publishDateSort | 2021 |
| record_format | marc |
| spelling | Richter, Jannis Verfasser aut Cellular adhesion differences at a blood brain barrier model between Natalizumab (Tysabri) Standard Interval Dosing and Extended Interval Dosing Therapy vorgelegt von Richter, Jannis Münster 2021 56 Blätter Illustrationen, Diagramme txt rdacontent n rdamedia nc rdacarrier Dissertation Westfälische Wilhelms-Universität Münster 2021 Zusammenfassung deutsch, Text englisch (DE-588)4113937-9 Hochschulschrift gnd-content |
| spellingShingle | Richter, Jannis Cellular adhesion differences at a blood brain barrier model between Natalizumab (Tysabri) Standard Interval Dosing and Extended Interval Dosing Therapy |
| subject_GND | (DE-588)4113937-9 |
| title | Cellular adhesion differences at a blood brain barrier model between Natalizumab (Tysabri) Standard Interval Dosing and Extended Interval Dosing Therapy |
| title_auth | Cellular adhesion differences at a blood brain barrier model between Natalizumab (Tysabri) Standard Interval Dosing and Extended Interval Dosing Therapy |
| title_exact_search | Cellular adhesion differences at a blood brain barrier model between Natalizumab (Tysabri) Standard Interval Dosing and Extended Interval Dosing Therapy |
| title_exact_search_txtP | Cellular adhesion differences at a blood brain barrier model between Natalizumab (Tysabri) Standard Interval Dosing and Extended Interval Dosing Therapy |
| title_full | Cellular adhesion differences at a blood brain barrier model between Natalizumab (Tysabri) Standard Interval Dosing and Extended Interval Dosing Therapy vorgelegt von Richter, Jannis |
| title_fullStr | Cellular adhesion differences at a blood brain barrier model between Natalizumab (Tysabri) Standard Interval Dosing and Extended Interval Dosing Therapy vorgelegt von Richter, Jannis |
| title_full_unstemmed | Cellular adhesion differences at a blood brain barrier model between Natalizumab (Tysabri) Standard Interval Dosing and Extended Interval Dosing Therapy vorgelegt von Richter, Jannis |
| title_short | Cellular adhesion differences at a blood brain barrier model between Natalizumab (Tysabri) Standard Interval Dosing and Extended Interval Dosing Therapy |
| title_sort | cellular adhesion differences at a blood brain barrier model between natalizumab tysabri standard interval dosing and extended interval dosing therapy |
| topic_facet | Hochschulschrift |
| work_keys_str_mv | AT richterjannis cellularadhesiondifferencesatabloodbrainbarriermodelbetweennatalizumabtysabristandardintervaldosingandextendedintervaldosingtherapy |